- Patients with ovarian, cervical, colon, gastric/gastroesophageal, non-small cell lung, renal cell, bladder and prostate cancer and osteosarcoma that is HER2 1+, 2+ or 3+ by IHC OR have a Vysis FISH result > 1.8.